VENCF (Vencanna Ventures) EBITDA Margin %: -55.74% (As of Jan. 2026)

What is Vencanna Ventures EBITDA Margin %?

Vencanna Ventures VENCF +80.00% EBITDA Margin % is -55.74% as of Jan. 2026. The stock has 4 warning signs investors should review. Among 955 Drug Manufacturers companies, Vencanna Ventures ranks worse than 91.83% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Vencanna Ventures's EBITDA for the three months ended in Jan. 2026 was $-0.23 Mil. Vencanna Ventures's Revenue for the three months ended in Jan. 2026 was $0.42 Mil. Therefore, Vencanna Ventures's EBITDA margin for the quarter that ended in Jan. 2026 was -55.74%.

Vencanna Ventures (OTCPK:VENCF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Vencanna Ventures EBITDA Margin % Related Terms

Vencanna Ventures EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Vencanna Ventures's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vencanna Ventures EBITDA Margin % Chart

Vencanna Ventures Annual Data

Trend

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Apr25

EBITDA Margin %

Get a 7-Day Free Trial

0.00

-75.50

Vencanna Ventures Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Oct25	Jan26
EBITDA Margin %	Get a 7-Day Free Trial															-150.36	-127.44	-102.86	-66.43	-55.74

VENCF vs ZTS: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vencanna Ventures's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vencanna Ventures EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vencanna Ventures's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Vencanna Ventures's EBITDA Margin % falls into.

Save Embed

Vencanna Ventures EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Vencanna Ventures's EBITDA Margin % for the fiscal year that ended in Apr. 2025 is calculated as

EBITDA Margin %	=	EBITDA (A: Apr. 2025 )	/	Revenue (A: Apr. 2025 )
	=	-3.03	/	4.013
	=	-75.50 %

Vencanna Ventures's EBITDA Margin % for the quarter that ended in Jan. 2026 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jan. 2026 )	/	Revenue (Q: Jan. 2026 )
	=	-0.233	/	0.418
	=	-55.74 %

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of -55.74% mean?

Vencanna Ventures (VENCF) has a EBITDA Margin % of -55.74% as of Jan. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vencanna Ventures and its competitors. According to the industry distribution chart, Vencanna Ventures ranks #877 out of 955 companies in the Drug Manufacturers industry, placing it in the top 91.8%.

Is Vencanna Ventures' EBITDA Margin % too high?

Vencanna Ventures' current EBITDA Margin % is -55.74%. Based on the distribution chart, Vencanna Ventures ranks #877 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.

How does Vencanna Ventures' EBITDA Margin % compare to ZTS?

According to the Drug Manufacturers industry distribution chart, Vencanna Ventures ranks #877 out of 955 companies for EBITDA Margin %. This places Vencanna Ventures in the lower half of its industry. The industry median EBITDA Margin % is 12.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Drug Manufacturers company?

The median EBITDA Margin % among Drug Manufacturers companies is 12.39, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vencanna Ventures and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vencanna Ventures's current EBITDA Margin % is -55.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Vencanna Ventures stock overvalued right now?

Vencanna Ventures (VENCF) has a current EBITDA Margin % of -55.74%. The current EBITDA Margin % is -55.74%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For Vencanna Ventures (VENCF), the current EBITDA Margin % is -55.74% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vencanna Ventures Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XCNQ:XTRX XCNQ:STKT XCNQ:OVAT TSXV:GENX XCNQ:PBF XCNQ:JOLT XCNQ:PHRX XCNQ:CRCC XCNQ:CPTR XCNQ:MJRX XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Other Exchanges VENI:Canada

Address 622 5th Avenue SW, Suite 200, Calgary, AB, CAN, T2P 0M6

Website https://www.vencanna.com

Vencanna Ventures Inc aims to provide investors with a diversified, high-growth, cannabis investment plan through strategic investments and acquisitions focused throughout the value chain (cultivation, processing, and distribution), including ancillary businesses. The company generates the majority of its revenue from the United States.